GE HealthCare Technologies Inc.
GEHC
Positions held
Your positionsGEHC isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- GE HealthCare is well-positioned in the medical devices industry, benefiting from a growing demand for advanced healthcare technologies.
- Revenue increased by 3% compared to the prior quarter, reaching $5.3 billion.
- Gross margin improved to 41.2%, up from 38.5% in the previous quarter.
- The company's current score indicates a 'Sell' signal, reflecting potential weaknesses in market performance.
- Operating margin has expanded to 14%, but this is still below the industry average.
- The stock has a trailing P/E of 14.89, which may suggest overvaluation compared to peers.
Fundamentals
| Market cap | $29.01B | Enterprise value | $37.71B | Trailing P/E | 14.76 | Forward P/E | 11.87 |
| PEG | 1.61 | Price / book | 2.64 | Beta | 0.85 | Dividend yield | 0.25% |
| Revenue growth | 5.8% | Earnings growth | 16.8% | Gross margin | 39.5% | Operating margin | 15.0% |
| Profit margin | 9.3% | ROE | 19.4% | ROA | 5.1% | Debt / equity | 0.94 |
| Current ratio | 1.26 | Free cash flow | $1.57B | Analyst recommendation | buy | Mean target | $82.90 |
| 52w high | $89.77 | 52w low | $58.75 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.1B | $5.7B | $5.1B | $5.0B | — |
| Op margin | 13.9% | 10.0% | 14.5% | 12.7% | 13.0% | — |
| Net income | $560M | $389M | $589M | $446M | $486M | — |
| Gross margin | 41.2% | 38.5% | 39.7% | 38.7% | 39.6% | — |
| Gross profit | $2.2B | $2.0B | $2.3B | $2.0B | $2.0B | — |
| Operating income | $738M | $515M | $827M | $653M | $652M | — |
- Revenue +3% vs prior quarter ($5.3B vs $5.1B).
- Gross margin 41.2% (was 38.5% prior quarter).
- Operating margin expanded to 14%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $20.6B | $19.7B | $19.6B | $18.3B | — |
| Op margin | 13.4% | 13.3% | 12.5% | 13.8% | — |
| Net income | $2.1B | $2.0B | $1.6B | $1.9B | — |
| Gross margin | 40.0% | 41.7% | 40.5% | 39.1% | — |
| Gross profit | $8.2B | $8.2B | $7.9B | $7.2B | — |
| Operating income | $2.8B | $2.6B | $2.4B | $2.5B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Why GE HealthCare (GEHC) Is Doubling Down on Pharmaceutical Diagnostics?
2026-10-08 · 2 Mid-Cap Stocks to Keep an Eye On and 1 We Question
2026-10-07 · Flutter upgraded, AppFolio downgraded: Wall Street's top analyst calls
2026-10-07 · GE HealthCare to announce third quarter 2026 results on October 28, 2026
2026-10-06 · The Bull Case For GE HealthCare (GEHC) Could Change Following Imaging Software Recall And Dividend Hike – Learn Why
2026-10-06 · GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal
2026-10-06 · What’s News: Business & Finance
2026-10-05 · Sector Update: Healthcare Stocks Advance Late Afternoon
2026-10-05 · GE Healthcare's Sofie Deal to Vertically Integrate Radiopharma Portfolio, Needham Says
2026-10-05 · Sector Update: Healthcare Stocks Rise Monday Afternoon
2026-10-05 · Sector Update: Healthcare
Price (daily)
Full chart · RSI · MACD · patterns